Orbicular Announces Health Canada Approval for a g-Ozempic (Semaglutide Injection) in Partnership with Apotex
Generic Semaglutide Injection developed by Orbicular receives Notice of Compliance from Health Canada — our second G-7 Approval by stringent regulatory authority (SRA) to greenlight...
